Following some great feedback and new business as a result of the talks we’ve given at the last 2 annual meetings (read my review of the 2014 event here, check out the slides from my ‘Smartphones: a clinical trial platform’ talk last year here and watch this 40 min video if you need a deep dive into how Mobile First Clinical Trials & Ratings are transforming the $100B Clinical Research Industry) we’ve been invited back to present on the topic of “What would happen if we took a mobile first approach when designing clinical trials?” at the 2016 Clinical Innovation Congress (and the collocated Clinical Outsourcing & Partnering Congress) which will be held at the Guoman Tower Hotel adjacent to Tower Bridge in London.
“Clinical trials are not working well enough to serve the needs of the industry or the patient. It is time to analyse what we are doing currently and how we can transform clinical practice. We need to disrupt the status quo, embrace technologies, new partnerships and new practices to create more patient- centric and efficient trials.
The 3rd annual Clinical Innovation Congress provides the perfect platform to do this, with insight from the pioneers who are driving clinical transformation. Discover new technologies and processes that offer viable and transformative solutions to universal clinical research hurdles. The parallel event, Clinical Outsourcing & Partnering World, will bring together clinical trial experts to examine outsourcing strategies and innovative partnering models”
Key insights you will get from attending the Clinical Innovation Congress:
- Explore how to disrupt clinical trials processes through innovation
- Bring the patient voice to the heart of your clinical strategy
- Hear from TransCelerate on their latest projects
- Avoid common industry stumbling blocks to drive efficiency and effectiveness in clinical research
- Discover the most disruptive and innovative technologies, offering real world solutions
- Adapting your business model – helping patients connect to clinical trials and ways to utilise data from previous products to develop a more patient-centric strategy.
Keynote Speakers will include:
Ornela Ademi, Scientific Officer, Norwegian Medicines Agency Amer Alghabban, VP Quality Assurance, Karyopharm
Janet Allen, Director Strategic Innovation, Cystic Fibrosis Trust
Munther Baara, Senior Director Technology, Pfizer @muntherbaara
Raja Banerji, Global Head, Tata Consultancy Services
Rob Barber, Associate Director, Alliance Management, Shire
Frank Behrens MD, Head of Clinical Research, University Hospital Frankfurt
Giles Breault, Principal, Beyond Group @GilesBreault
Ulrich Bruggeman, External Opportunity Leader, Sanofi
Matt Cooper, Business Development and Marketing Director, NIHR Clinical Research Anish Desai, Medical Affairs, Janssen Pharmaceutical Companies, J&J
Rob DiCicco, Vice President, GlaxoSmithKline
Bryan Dobson, Associate Director, DrugDev
David Doherty, coFounder, 3G Doctor
Christian Gossens, Global Head Early Development, Roche
Jason Gubb, VP, GlaxoSmithKline
Chris Hart, Information Science and Informatics Director, AstraZeneca
Bert Hartog, R&D Innovation Leader, Janssen
Ian Hodgson, Head of Clinical Operations, Mereo BioPharma
Anthony Hörning, Founder, Strategic Transactions Advisory AG
Leo James, Associate Director, Medical Affairs, Clinical Trials, Astellas
Ramona Kanters, CEO and Chair, OPEN
Robert Kroes, Project Lead, Clinical Open Innovation Europe, Eli Lilly
Andy Lawton, Global Head Clinical Data Management, Boehringer Ingelheim
Yuri Martina, Vice President, Clinical Operations, Shionogi
Cathy McDowell, Head of Clinical Operations, Cancer Research UK
Pete Milligan, Vice President, Clinical Platforms Transformation, GSK
Willie Muehlhausen, VP eCOA & Innovation, ICON
Tim Omer, Patient Inventor and Advocate
Adrian Otte, VP Global Development, Amgen
Michael Parnham, Professor Pharmacology and Toxicology, University of Frankfurt
Christian Pasquali, Head of Preclinical Research, Vifor Pharma
Libby Peer, Head of Clinical Operations, Teva
Pasi Piitulainen, Head Global Procurement, Actelion
Johann Proeve, Global Development and Strategy Advisor, Data Sciences and Analytics, Bayer
Sammy Rashed, Principal & coFounder, Beyond Group
Dror Mesilati Segev, Global Patient Safety Pharmacovigilance & R&D, Teva
Michael Seres, Co-founder, 11health
Nadia Turner, Alliance Management Director, AstraZeneca
Hitesh Varambhia, Founder and Director, Varambhia and Associates Limited
Kirsty Wydenbach, Medical Assessor, Clinical Trials Unit, MHRA
Jesus Zurdo, Head of Strategic Innovation, Lonza
Want to get involved in the Clinical Innovation Congress?
If you have a solution that you would like to share at the event or have any questions about participation please contact Alison Jack at [email protected]
Follow the event on Twitter #CIC2016
*** *** UPDATE 7 March 2016 *** ***
The finalised title of my talk is “What would happen if we took a Mobile First approach when designing Clinical Trials?” and if you check back here on Thursday 10th March you’ll be able to view my slide deck and watch a video recording of my talk.
I’ll end the presentation with a call to collaborate as we’re working with a few organisations that would like to launch Mobile First Clinical Trials trials so if you would like to explore opportunities to work with us let’s make time to meet up.
To make an appointment comment or request an invite to join us at the Wednesday evening dinner email david_dohertyAT3GDoctorDOTcom:
Appointment times available:
Wednesday 8-9am Available
Wednesday 10-10:30am Available
Wednesday 11:00am-11:30am Available
Wednesday 12:00 – 12:30pm Reserved
Wednesday 2:30-3:00pm Available
Wednesday 3pm – 3.30pm Reserved
Wednesday 8pm Harley Street Dinner
Thursday 8:30am-9am Available
Thursday 11 – 12.00pm PRESENTING
Thursday 12 – 1pm Roundtable discussion
Thursday 2.30-3pm Available
*** *** UPDATE 8 March 2016 *** ***
At noon on Thursday following my presentation there will be three peer-to-peer roundtable discussions lasting 30 minutes and I’ll be leading one of them:
- The Challenges to Building Mobile 1st Clinical Trials (David Doherty, coFounder & Director, 3G Doctor)
- How to negotiate the best outsourcing contract for your project (Hitesh Varambhia, Founder and Director, Varambhia and Associates Limited)
- How to achieve excellence in clinical relationship management (Johann Proeve, Global Development and Strategy Advisor, Data Sciences and Analytics, Bayer)
Please join me for this also!
*** *** UPDATE 10 March 2016 *** ***
Slides: